Press Release
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential to treat cancer, autoimmune conditions, neurodegeneration, and metabolic disorders through epigenetic modulation. Read More
Press Release
5E Advanced Materials Publishes Fort Cady Project SK-1300 Pre-Feasibility Technical Report with a US$724.8M Pre-Tax NPV7, 19.2% IRR, Initial 39.5-Year Mine Life
Technical Report Underscores Large, Multi-generational High-Grade Colemanite Deposit to Support Domestic Supply of Boron Amid Growing Demand Read More
Press Release
Massachusetts Cannabis Contamination Crisis Exposes Federal Negligence While DEA Targets Science, Not Safety
Where Is the DEA? The Real Threat Isn't Research-It's Rotten Weed. "This is the height of hypocrisy," said Duane Boise, CEO MMJ. "DEA bureaucrats are blocking clean cannabis grown in a DEA inspected cultivation facility, while contaminated products circulate freely under their watch. The agency has abandoned its duty to protect patients." Read More
Press Release
Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update
NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis (PsO) submitted to U.S. FDA in July ANTHEM Phase 2b trial data of icotrokinra in ulcerative colitis scheduled for an oral presentation at the 33rd United European Gastroenterology Week (UEGW) on October 7th Phase 3 VERIFY trial data set of rusfertide in polycythemia vera (PV) presented during plenary session at ASCO; U.S. NDA filing on track for Q4 Cash, cash equivalents and marketable securities of $673.0 million as of June 30, 2025, anticipated to provide cash runway through at least end of 2028 Read More
Press Release
ATA Creativity Global Reports Q2 2025 Financial Results
Reports Q2 2025 Net Revenues and Gross Profit Increases of 8.0% and 10.2%, Respectively, as Compared to Q2 2024 Conference Call Scheduled for Wednesday, August 6, at 9:00 p.m. Eastern Time (Thursday, August 7, at 9:00 a.m. Beijing Time) with Accompanying Audio and Slide Webcast Read More
Press Release
Selling a Small Business: Expert Guide Released by IRAEmpire
Small business owners who want to exit their venture profitably can read the free guide released by IRAEmpire. It covers various aspects of selling a small business and gives valuable tips on how to expedite the process. Read More
Press Release
Electromedical Technologies, Inc. (OTC: EMED) Provides Mid-Year Update Highlighting Financial Restructuring, Regulatory Alignment, and Strategic Progress
Electromedical Technologies (OTC: EMED) outlines key financial restructuring milestones, upcoming product updates, and new strategic partnerships to drive sustainable growth in the pain management market. Read More
Press Release
Honeycomb Insurance Announces Partnership with Trisura to Expand Admitted Capacity
Honeycomb more than doubled its sales in 2024 while maintaining exceptional loss ratios. This partnership with a leading insurer expands its admitted footprint across 18 states, key to meeting future capacity needs and sustaining growth. Read More
Press Release
Naples Brothers Build Vacation Rental Powerhouse, Disrupting a Decades-Old Industry
Jake and Keith Ponsler's Naples Vacation Properties now controls over 25% of the Naples vacation rental search market -with plans to expand nationally and become the #1 operator in Southwest Florida. Read More
Press Release